Christina Kong
Academic Appointments
- Associate Professor - Med Center Line, Pathology
Key Documents
Contact Information
-
Clinical Offices
Surgical Pathology 300 Pasteur Dr H2110 MC 5243 Stanford, CA 94305 Tel Work (650) 723-7211 Fax (650) 725-6902Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information EmailAlternate Contact Darlene Washington Administrative Assistant Email Tel Work 650-725-0405Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Anatomic/Clinical Pathology
- Cytopathology
- Gynecologic & Breast Pathology
- Head & Neck Pathology
Administrative Appointments
- Director, Cytopathology Laboratory (2006 - present)
- Director, Cytopathology Fellowship (2003 - present)
- Acting Director, Cytopathology Laboratory (2004 - 2005)
- Associate Director, Cytopathology Laboratory (2002 - 2003)
Professional Education
| Board Certification: | Anatomic/Clinical Pathology, American Board of Pathology (1999) |
| Board Certification: | Cytopathology, American Board of Pathology (2000) |
| Fellowship: | Stanford University School of Medicine CA (1997) |
| Internship: | UCSF Medical Center CA (1993) |
| Medical Education: | UCSF School of Medicine CA (1992) |
| MD: | UC San Francisco (1992) |
Graduate & Fellowship Program Affiliations
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information
Scientific Focus
Current Research Interests
Improving the accuracy of cytologic diagnosis through refining diagnostic criteria and the use of ancillary techniques (e.g. immunoperoxidase stains, flow cytometry, in situ hybridization, PCR) on specimens obtained by the minimally invasive technique of fine needle aspiration biopsy.
Identifying potential indicators of prognosis in head and neck squamous cell carcinomas.
Evaluating the utility of immunohistochemical stains in refining the diagnosis of squamous dysplasia of the cervix, vulva, and head and neck.
Clinical Trials
- Recruiting Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level
- Not Recruiting Phase II Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
- Not Recruiting Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation
- Not Recruiting Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
Publications
- Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues. Arch Pathol Lab Med. 2013; (1): 50-4
- Loss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013; (1): 95-103
- Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors. Int J Gynecol Pathol. 2012; (5): 463-9
- CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012; (6): 465-70
- Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas. Am J Surg Pathol. 2012; (8): 1158-64
- Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer. Clin Cancer Res. 2012; (6): 1798-807
Help